Clinical Practice Guideline on the Management of Major Depression in Adults.

Full version

  1. Introduction
  2. Scope and objectives
  3. Methodology
  4. Definition and diagnosis of major depression
  5. Pharmacological treatment
  6. Psychotherapy
  7. Other treatments
  8. Quality indicators
  9. Dissemination and implementation
  10. Recommendations for future research
  11. Appendices
  12. Bibliography
  13. Full list of tables and figures

Abre nueva ventana: Apartado 07 en versión pdf Download Section 07 (432 Kb)
Download Depression in Adults CPG (4.8 Mb)

7. Other treatments

Questions to be answered

  • Is electroconvulsive therapy effective for the treatment of major depression?
  • Is guided self-help effective for any sub-group of patients?
  • Are support groups effective for patients with major depression?
  • Is physical exercise effective for patients with major depression?
  • Is acupuncture effective for patients with major depression?
  • Is treatment with St John’s Wort effective?

7.1. Electroconvulsive therapy

Electroconvulsive therapy (ECT) induces, for a therapeutic purpose, generalised seizure activity through electrical stimulation of the central nervous system. Even though years ago it was a reviled and even prohibited technique, today it is performed under certain circumstances, under anaesthetic control and with muscle relaxation, wherefore secondary effects have been reduced to the point where they are comparable to those of general anaesthesia.

Even though electroconvulsive therapy has been used in clinical practice for more than 50 years, there continues to be controversy about the pathologies for which it could be indicated, as well as its efficacy, how it is administered, the possible complications and its indication as maintenance treatment. Despite all this, ECT has proven its efficacy in various studies, and it is used in severe depressive episodes, with or without psychotic symptoms, and in resistant depression. It should also be considered as first-line treatment in acute situations of suicidal risk or for patients who have severely deteriorated medically21, 132.

There are no absolute contraindications for electroconvulsive therapy, although there are situations of relative risk, such as the presence of brain injuries that occupy space (tumours or haemorrhages) or any other situation in which intercranial pressure is high; recent cardiovascular problems (such as acute myocardial infarction or vascular malformations); treatment with MAOIs or lithium; and the existence of increased risk for general anaesthesia133. Regarding side effects, they depend basically on the patient’s previous conditions, their personal susceptibility, the technique used (bilateral or unilateral), the number of sessions used and the frequency of administration. These side effects can be immediate (mental confusion, amnesia and headache) or more persistent (euphoria and cognitive disorders)132.

In 1999, the Sociedad Española de Psiquiatría [Spanish Society of Psychiatry] promoted the formulation of a Spanish consensus on electroconvulsive therapy, in which it was agreed that maintenance ETC could benefit 10-15% of patients with severe affective disorders in which relapses occur (even with adequate drug treatments) during the 6 months following the ECT134.

The ECT section of the NICE21 Depression CPG is based on a systematic review prepared by the University of Sheffield and subsequently published in 200521, 135 and it in turn includes two systematic reviews of quality randomised clinical trials. The first, prepared by the Cochrane Collaboration, studied the efficacy and safety of ECT in schizophrenia136, and the second, performed by the UK ECT Group, studied the efficacy of ECT on the depressive illness137. It also included a systematic review of non-randomised studies on the patients’ point of view about this technique138; two clinical studies in which ECT was compared with transcranial magnetic stimulation; ten studies in which ECT combined with drugs was compared to ECT plus placebo; a prospective cohort study in which patients of advanced age who had received ECT were compared to those who had not received it139; and a systematic review of a series of cases on using ECT during pregnancy140, 141.

The NICE CPG considers ECT to be an effective treatment for depression in adults and it reaches the following conclusions:

  1. ~ Real ECT is more effective than sham ECT, although the parameters of the electrical stimulus have an important influence on efficacy.
  2. ~ Bilateral ECT is more effective than unilateral ECT, and unilateral ECT at a low dose is not more effective than sham ECT.
  3. ~ ECT has the risk that side effects of the cognitive type may appear. Even though the evidence is limited, it seems that the duration of these effects does not go beyond six months, although there are no longer-term studies.
  4. ~ ECT is probably more effective than short-term pharmacotherapy, although the evidence of this affirmation is based on studies of inadequate variable quality and doses.
  5. ~ The combination of ECT with pharmacotherapy was not shown to have a greater short- term effect than ECT alone.
  6. ~ There is limited information to the effect that ECT is more effective than repetitive transcranial magnetic stimulation.
  7. ~ Certain data suggest that tricyclic antidepressants could improve the effect of ECT and that the continuation of treatment associated with lithium reduces the rate of relapses in patients who have responded to ECT after an acute episode.
  8. ~ Finally, the meta-analysis prepared by Kho et al142 and based on 16 clinical trials included in most of the preceding reviews supports the aforementioned conclusions.

Summary of the evidence

1+ There are numerous controlled studies that demonstrate that electroconvulsive therapy is an effective and safe treatment in adult patients with severe major depression (133, 135, 140).
1+ The parameters of the electrical stimulus have a major influence on the efficacy of the technique, and bilateral ECT is more effective than unilateral ECT (133, 135, 140).
1+ ECT is a safe technique, and its side effects on memory are usually slight and temporary (133, 135, 140).
1+ ECT is more effective in the short-term than pharmacotherapy, and the combination of ECT with pharmacotherapy has not shown to have a greater short-term effect than ECT alone (133, 135, 140).
1+ Tricyclic antidepressants improve the effect of ECT, and continuing with antidepressant treatment associated with lithium could reduce the rate of relapses in patients who have responded to ECT after an acute episode (133, 135, 140).

Recommendations

A Electroconvulsive therapy should be considered as a therapeutic alternative in adults with severe major depression.
ECT is especially indicated for patients with severe major depression (with a high risk of suicide or severe physical impairment), in resistant depression and by informed choice of the patient.
top

7.2. Guided self-help

Guided self-help is an ambiguous term that includes self-help as such and guided self-help. Self-help is directed at improving the clinical outcome by training patients on the pertinent skills for overcoming and managing their health problem. It includes the use of written materials (bibliotherapy), computer programmes or material recorded in audio/video format so that, for the purpose of modifying their attitudes and behaviour, they successfully solve or improve their problems.

In turn, guided self-help is more complete and uses these self-help materials in conjunction with minimum guidance offered by a professional “to monitor progress, clarify the procedures, respond to general questions or provide general support or stimulus”143.

Reading the existing literature on this subject brought several questions to light:

  1. ~ First of all, the self-help material for depression is scarce, it is in English, and it always alludes to two texts of reference: Feeling Good, The New Mood Therapy, by David Burns, whose version in Spanish is called Sentirse bien144; and Managing anxiety and depression145, which has been translated into Spanish under the title of Manejando su ansiedad y depresión. A single article refers to a third book titled Control your depression146. We are unaware if these books have been validated in Spanish and if they are actually used as bibliotherapy material in consultations.
  2. ~ Most studies refer to the fact that the therapist is the one to deliver the reading material, with minimum intervention. Moreover, there was considerable variation in the range of patients to whom bibliotherapy was offered.
  3. ~ There is considerable heterogeneity about the diagnosis and classification of depression, and on many occasions neither criteria nor scales considered to be of reference in this guide are used.
  4. ~ The use of different nomenclatures and, occasionally, combinations of techniques was observed, which limits the assessment.

NICE assessed guided self-help through nine randomised clinical trials, and it concluded that guided self-help generates a significant clinical reduction of depressive symptoms in comparison to non-intervention. In patients with mild or moderate depression, it could be as effective as some forms of individual therapy and more effective than group psychotherapy, although there isn’t sufficient data to the effect that this benefit is maintained in the long term21. The recommendations that it makes are the following:

  1. ~ In patients with mild depression, health professionals should recommend guided self-help programmes based on cognitive behavioural therapies.
  2. ~ Guided self-help, in addition to providing suitable written material, must include support and follow-up by health professionals for six to nine weeks.

Bibliotherapy in the treatment of depression was assessed in a meta-analysis147, and it was observed that using bibliotherapy translated into at least a 25% reduction in scores of depression tests when compared to non-treatment, although there was no significant relationship between the maintenance time of the treatment and the final clinical outcome. Up to now, there are no clinical trials that demonstrate that bibliotherapy is helpful in patients with severe depression.

A randomised controlled trial148 examined if the fact that adding self-help material (books, brochures, algorithms, etc.) to the standard treatment of depression using antidepressants by primary care physicians was associated with any additional improvement of the clinical outcomes. The outcomes showed no significant reduction between the patients treated only with antidepressants and those who also received self-help. However, significant differences were observed in favour of the intervention group with respect to knowledge of the treatment, of the illness, of how to make changes in their lives and of the effects of the medication. The patients were shown to be satisfied with receiving self-help, and most general physicians found it to be useful.

Summary of the evidence

1+ Compared to non-intervention, guided self-help is effective at reducing the symptoms of mild to moderate depression, although its long-term effect is unknown (21).
1+ No significant differences were observed when the pharmacological treatment of depression was compared to adding or not adding self-help (146).

Recommendations

In general, guided self-help is not recommended for patients with severe major depression.
B However, for patients with mild or moderate depression, professionals could consider recommending guided self-help programmes based on cognitive behavioural therapy.
top

7.3. Support groups

A mutual support group is understood as a group specifically created to help its members face a critical life situation, such as chronically mental ill persons, and to inform, guide and support families, thereby offering resources for supporting the anxiety and bearing the prejudices linked to the ignorance of certain illnesses. These “non-professional” groups and networks work autonomously and arise in society when formal healthcare organisations do not satisfy certain needs. The most well-known examples are alcoholics anonymous groups and self-help programmes for food disorders. These groups are considered to be mainly self-sufficient and usually have no professional interference.

Conversely, support groups tend to be called together by a professional and are composed of people who share some type of problem that alters or modifies aspects of their normal functioning. Belonging to these groups provides new links and social relationships for their members, thereby allowing interaction with people who have common problems, deficiencies and/or experiences. A group can begin by being a support group and over time become a mutual support group that operates autonomously, although this group may likewise and occasionally require the help of a professional or of an institution and operate for a certain period of time like a support group.

Occasionally, these groups can be guided by paraprofessionals who are trained or supervised by professionals. They are defined as mental health workers, paid or volunteers, without training regarding psychological treatment for anxiety and depression, and who substitute professionals in treating patients with these disorders149.

In this section, the NICE21 guideline only included one randomised clinical trial that used befriending of women with depression. It consisted of especially trained volunteers who got to know, speak with and accompany women with depression for at least one hour a week, which women were also allowed another type of treatment. The outcomes showed that friendship is significantly effective at achieving the remission of depressive symptoms in comparison with controls. NICE concludes with the recommendation that in patients with chronic depression, friendship could be considered an adjuvant to pharmacological or psychological treatment.

In a prospective cohort study not included by NICE150 , the use of depression support forums through the Internet was assessed. The patients that customarily used these forums (more than five hours a week) showed a better resolution of their depressive symptoms. However, the high probability of skewing of this study must be considered, given that it used patients who had different states and who were socially isolated.

Support and socialisation groups seem to constitute protector factors in older persons with depression, while sensory limitations, such as blindness and deafness, the absence of a home and low financial income behave like depression risk factors151. Finally, a satisfaction study showed that up to 64% of the participants in depression support groups declared that this type of therapy met their expectations152.

Summary of the evidence

  Studies about support and self-help groups are scarce and of insufficient quality to determine if they can be beneficial or not in patients with major depression.

Recommendations

Participation in support groups is not considered an effective treatment measure in patients with the major depressive disorder, either alone or combined with other therapeutic measures.
top

7.4. Physical exercise

It is well-known that exercise improves the mood and the general sensation of well-being, wherefore it has been attempted to determine up to what point it can be useful as treatment in patients with major depression. A depressed patient who exercises regularly successfully develops his self-esteem and develops better and greater support from others, which favours his relationships with the environment.

NICE21 performed a systematic review on the likelihood of remission, reduction of symptoms and adherence to treatment in patients with depression who took exercise, versus not exercising and versus different available treatments (pharmacological, psychotherapeutic, social support and meditation), thereby including a total of nine clinical trials. In general, the exercise programmes used had a relatively high frequency (at least 3 times per week), lasting from 45 minutes to one hour and in periods of 10 to 12 weeks. The conclusions were that in subjects with depression, in particular mild or moderate depression, structured and supervised exercise had a clinically significant impact on improving the symptoms, even though there was no evidence of long-term benefits for preventing relapses or of the utility of maintenance exercise programmes. There also was insufficient evidence to assess its usefulness as an alternative or in combination with other treatments, although a recent study – with few patients – points out that endurance exercise associated with antidepressant drugs is better than antidepressant drugs alone153.

One trial with considerable methodological limitations (small sample size, poor definitions of exercise time and intensity, low number of participants among those potentially eligible and no assessment of comorbidities) and not included in the NICE guideline compared physical exercise to educational activities in patients without clinical improvement after six weeks of pharmacological treatment at suitable doses154. The authors observed that exercise twice a week provides a greater reduction of depressive symptoms, even though the exercise may be light.

Another systematic review155, which only included three studies with patients with major depression, observed that physical exercise programmes significantly reduce the symptoms of depression, although the conclusions are limited by the heterogeneity of the three assessed studies and their methodological limitations.

The efficacy of exercise in patients with mild and moderate major depression and their dose-response ratio was evaluated in a trial in which only 5% of the potentially eligible patients initiated it156. The authors conclude that aerobic exercise at the traditionally recommended doses (17 kcal/kg/week, taken 3 to 5 times per week) improves the symptoms of depression, while exercise at low doses (7 kcal/kg/week) has no effect at all.

Finally, in patients over 60 years of age, intense exercise also seems to be more effective than low intensity exercise or the usual care by the primary care physician157.

Summary of the evidence

2++ For patients with major depression, in particular mild to moderate depression, a structured and supervised programme of exercise could be effective intervention, with significant clinical impact on depressive symptoms (21).
2+ Although the acceptance rate of exercise programmes is low, once one is started, adherence is similar to other types of therapies, and short-term benefits are detected (21).
2++ The greatest beneficial effect of exercise is obtained when it is given in association with pharmacological or psychotherapeutic treatment (151).
  No evidence has been found about the usefulness of exercise for maintenance therapy or for the prevention of relapses.

Recommendations

C Programmes of structured and supervised exercise of moderate intensity, with a frequency of 2-3 times per week, with a duration of 40-45 minutes and for a period of 10 to 12 weeks should be recommended to patients with mild-moderate depression.
top

7.5. Acupuncture

Acupuncture is a technique that consists of inserting thin needles in various parts of the body, and it is based on traditional Chinese medicine. There are a wide variety of techniques, which include the classic or traditional, auricular, trigger points and single points.

The use of acupuncture was not discussed in the NICE21 CPG. We identified three systematic reviews and one subsequent clinical trial with which we used to deal with the question. The first review158 included 7 randomised clinical trials, six of which included only patients with major depression (a total of 466 patients). The second review, published by the Cochrane Collaboration159, included seven randomised clinical trials (a total of 517 patients), five of which were included in the first158. A final review160 included nine randomised clinical trials, eight of which included only patients with major depression (614 patients). All the clinical trials of the first review158 were included in the latter, and only one from the Cochrane review159 was not included.

The inclusion criteria considered in the reviews were randomised clinical trials that compared acupuncture (specific for depression or not) to simulated acupuncture, pharmacological treatment or no treatment, and all the trials included in the three reviews were considered to be poor quality.

In general, the reviews coincide in that there is insufficient scientific evidence to determine if specific acupuncture for depression is more effective than non-specific acupuncture or no treatment, or if acupuncture plus medication is more effective than acupuncture plus placebo. Moreover, the aforementioned methodological aspects mean that the outcomes must be interpreted with caution.

A final, double-blind, randomised clinical trial not included in the previous reviews and performed on 151 patients diagnosed with major depression compared traditional Chinese acupuncture to manual stimulation and to a control group161. It concluded that, even though acupuncture seems to improve the treated patients with respect to the wait-list patients, there are no data as to different efficacy between the two types of acupuncture, and it concluded that acupuncture with manual stimulation is not effective as monotherapy in major depression.

Summary of the evidence

  The available trials lack suitable methodological rigour, wherefore it is not possible to determine if acupuncture, whether specific for depression or not, alone or in combination with other treatments, has a beneficial effect in patients with symptoms of major depression.

Recommendations

The existing scientific evidence does not allow recommending the use of acupuncture as a treatment for major depression.
top

7.6. St John’s Wort

The extract of hypericum perforatum, commonly called St John’s Wort, is a product that has been used for centuries, and it has at least seven components that can contribute to its pharmacological effects162. Their action mechanism is not entirely clear163. Easy access, its low cost and the general belief that it has no side effects164 have caused a considerable increase in the use of herbal products for treating depression.

The NICE21 CPG on managing depression selected forty trials pertaining to the use of St John’s Wort in treating depression, out of which only 19 finally met the criteria for inclusion. The comparison groups were the placebo (10 articles), tricyclic antidepressants (four articles), serotonin reuptake inhibitors (six articles) and antidepressants related to tricyclics (one article). The conclusions were that St John’s Wort seems to be more effective than the placebo at obtaining a response, both in moderate depression and in severe depression, and there are no differences when compared to other antidepressants. Despite the fact that St John’s Wort could be beneficial in cases of mild and moderate depression, the authors of the guideline recommend that health professionals do not prescribe it due to the uncertainty of the appropriate dose, the variation in the nature of the existing preparations and the potential interactions with other drugs, such as oral contraceptives, anticoagulants and anticonvulsants. Moreover, patients who may be receiving St John’s Wort should be suitably informed about the aforementioned.

A subsequent Cochrane review identified 37 trials that compared St John’s Wort with placebo or with other antidepressants165. This review includes most of the trials of the NICE review21. In adults with mild to moderate depression, St John’s Wort improved symptoms more than placebo and than standard antidepressants. When jointly analysing the six most recent trials, all of large size, with an improved design and including only patients with major depression, the observed benefits of hypericum over placebo were minimal. This leads to considering a possible CLINICAL PRACTICE GUIDELINE ON THE MANAGEMENT OF MAJOR DEPRESSION IN ADULTS 63 over-estimation of the effect in the older studies and in those of a smaller sample size. The authors conclude that the comparison of St John’s Wort to placebo only seems to have fewer benefits in patients with major depression, that there possibly is no benefit in patients with prolonged depression and that there is no evidence as to its effectiveness on major depression. A third systematic review166 in which the outcomes of two meta-analyses were compared, one that included 15 studies published between 1979 and 2000 and the second in which three new studies are added to the previous ones, does not contribute relevant data to the review prepared by the Cochrane Collaboration165.

Summary of the evidence

  St John’s Wort or hypericum perforatum is an herbal product frequently used for treating depression due to its easy access and low cost. However, there is uncertainty about the appropriate dose, and complications can appear when using it due to the variation of the nature of the existing preparations and to the potential interactions with other drugs (160).
1+ Current scientific information about the efficacy of St John’s Wort for treating depression is heterogeneous, and there may be an over-estimation of its effect. In patients with major depression, only minor benefits would be obtained, and possibly none in patients with a prolonged duration of their depression (21, 163).

Recommendations

B The use of St John’s Wort is not recommended as a treatment option for patients with major depression.
Health professionals should inform patients who consume it about the possible risks and benefits.
top

Section 07 Bibliography


  1. 21. NICE. Depression: management of depression in primary and secondary care: National Clinical Practice Guideline number 23; 2004 December 2004.
  2. 132. Kennedy SH, Lam RW, Cohen NL, Ravindran AV. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 2001;46 Suppl 1:38S-58S.
  3. 133. Department of Veterans Aff airs/Department of Defense (VA/DoD). Clinical practice guideline for the management of major depressive disorder in adults. . Virginia: West Virginia Medical Institute; 2000.
  4. 134. Sociedad Española de Psiquiatría. Consejo español sobre la terapia electroconvulsiva (TEC), 1999.citado 1 octubre 2007; Available at: http://www.medicinainformacion. com/documentos/consensotec.pdf
  5. 135. Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. Health Technol Assess 2005;9(9):1-156, iii-iv.
  6. 136. Tharyan P, Adams C. Terapia electroconvulsiva para la esquizofrenia (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 3. Oxford: Update Software Ltd. Available at: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.), 2005.
  7. 137. UK ECT Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003;361(9360):799-808.
  8. 138. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. Patients’ perspectives on electroconvulsive therapy: systematic review. BMJ 2003;326(7403):1363.
  9. 139. Rubin EH, Kinscherf DA, Figiel GS, Zorumski CF. The nature and time course of cognitive side effects during electroconvulsive therapy in the elderly. J Geriatr Psychiatry Neurol 1993;6(2):78-83.
  10. 140. Bhatia SC, Baldwin SA, Bhatia SK. Electroconvulsive therapy during the third trimester of pregnancy. J Ect 1999;15(4):270-4.
  11. 141. Echevarria Moreno M, Martin Munoz J, Sanchez Valderrabanos J, Vazquez Gutierrez T. Electroconvulsive therapy in the first trimester of pregnancy. J ECT 1998;14(4):251-4.
  12. 142. Kho KH, van Vreeswijk MF, Simpson S, Zwinderman AH. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 2003;19(3):139-47.
  13. 143. Gould R, Clum G. A meta-analysis of self-help treatment approaches. Clin Psychol Rev 1993;13:169-86.
  14. 144. Burns D. Sentirse bien. Una nueva terapia para las depresiones. Barcelona: Paidós; 1999.
  15. 145. Holdsworth N, Paxton R. Managing anxiety and depression. London: Mental Health Foundation; 1999.
  16. 146. Lewinsohn P, Forster R, Youngsen M. Control your depression. Alaska: Fireside; 1992.
  17. 147. Gregory R, Canning S, Lee T, Wise JC. Cognitive bibliotherapy for depression: a metaanalyisis. Prof Psychol 2004;35(3):275-9.
  18. 148. Salkovskis P, Rimes K, Stephenson D, Sacks G, Scott J. A randomized controlled trial of the use of self-help materials in addition to standard general practice treatment of depression compared to standard treatment alone. Psychol Med 2006;36(3):325-33.
  19. 149. den Boer PCAM WD, Russo S, van den Bosch RJ. Paraprofesionales para el tratamiento de la ansiedad y los trastornos depresivos. En: La Biblioteca Cochrane Plus, 2007 Número 3. Oxford: Update Software Ltd. Available at: http://www.update-software. com. (Traducida de The Cochrane Library, 2007 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.).
  20. 150. Houston TK, Cooper LA, Ford DE. Internet support groups for depression: a 1-year prospective cohort study. Am J Psychiatry 2002;159(12):2062-8.
  21. 151. Tuesca-Molina R, Fierro Herrera N, Molinares Sosa A, Oviedo Martinez F, Polo Arjona Y, Polo Cueto J, et al. Los grupos de socializacion como factor protector contra la depresion en personas ancianas. Baranquilla, Colombia. Rev Esp Salud Publica 2003;77(5):595-604.
  22. 152. Cheung A, Chung H, Wong S, Chan W, Li H. Depression Support Group: Participants’ Evaluation and Perceived Effects. Hong Kong Pract 2006;28(1):14-23.
  23. 153. Knubben K, Reischies FM, Adli M, Schlattmann P, Bauer M, Dimeo F. A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression. Br J Sports Med 2007;41(1):29-33.
  24. 154. Mather AS, Rodriguez C, Guthrie MF, McHarg AM, Reid IC, McMurdo ME. Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder: randomised controlled trial. Br J Psychiatry 2002;180:411-5.
  25. 155. Sjosten N, Kivela SL. The effects of physical exercise on depressive symptoms among the aged: a systematic review. Int J Geriatr Psychiatry 2006;21(5):410-8. 156. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med 2005;28(1):1-8.
  26. 157. Singh NA, Stavrinos TM, Scarbek Y, Galambos G, Liber C, Fiatarone Singh MA. A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci 2005;60(6):768-76.
  27. 158. Mukaino Y, Park J, White A, Ernst E. The effectiveness of acupuncture for depression -a systematic review of randomised controlled trials. Acupunct Med 2005;23(2):70-6.
  28. 159. Smith C, Hay P. Acupuntura para la depresión. (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 3. Oxford: Update Software Ltd. Available at: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.). 2006.
  29. 160. Leo RJ, Ligot J, . A systematic review of randomized controlled trials of acupuncture in the treatment of depression. J Affect Disord 2007;97(1-3):13-22.
  30. 161. Allen JJ, Schnyer RN, Chambers AS, Hitt SK, Moreno FA, Manber R. Acupuncture for depression: a randomized controlled trial. J Clin Psychiatry 2006;67(11):1665-73.
  31. 162. Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry 1997;30 Suppl 2:129-34.
  32. 163. National Prescribing Centre. St John’s wort: is it effective in depression? In: MeReC Extra 2001.
  33. 164. FDA Public Health Advisory. Risk of drug interactions with St John’S Wort and indinavir and other drugs. Internet. Center for Drug Evaluation and Research, 2007.citado 1 octubre 2007; Available at: http://www.fda.gov/Cder/drug/advisory/stjwort.htm.
  34. 165. Linde K, Mulrow C, Berner M, Egger M. Hierba de San Juan para la depresión. (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 3. Oxford: Update Software Ltd. Available at: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.). 2007.
  35. 166. Werneke U, Horn O, Taylor DM. How effective is St John’s wort? The evidence revisited. J Clin Psychiatry 2004;65(5):611-7.

Latest update: May 2009

Logo del Ministerio de Sanidad y Consumo Logo del Plan de Calidad del Sistema Nacional de SaludAxencia de Avaliación de Tecnoloxías Sanitarias de Galicia

 

Copyright | Help | Map